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Edited by Peter BrzezinskiAbstract Transhydrogenase couples the redox reaction between
NAD(H) and NADP(H) to proton translocation across a mem-
brane. In membrane vesicles from Escherichia coli and Rhodo-
spirillum rubrum, the transhydrogenase reaction (measured in
the direction driving inward proton translocation) was inhibited
by Zn2+ and Cd2+. However, depending on pH, the metal ions
either had no eﬀect on, or stimulated, ‘‘cyclic’’ transhydrogena-
tion. They must, therefore, interfere speciﬁcally with steps
involving binding/release of NADP+/NADPH: the steps thought
to be associated with proton translocation. It is suggested that
Zn2+ and Cd2+ bind in the proton-transfer pathway and block in-
ter-conversion of states responsible for changing NADP+/
NADPH binding energy.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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proteins1. Introduction
Transhydrogenase is found in the inner mitochondrial mem-
branes of animal cells and the cytoplasmic membranes of bac-
teria. It couples the redox (hydride transfer) reaction between
NAD(H) and NADP(H) to proton translocation across the
membrane (reviewed [1])
NADHþNADPþ þHþout $ NADþ þNADPHþHþin ð1Þ
where Hþout and H
þ
in are, respectively, the hydrogen-ion activi-
ties outside and inside the intact mitochondrion or bacterium.
Under physiological conditions, transhydrogenase normally
utilises the proton electrochemical gradient generated by the
respiratory (or sometimes photosynthetic) electron transport
chains to drive NADP+ reduction.
The enzyme has a tripartite structure. The dI component,
which binds NAD(H), and the dIII component, which binds
NADP(H), protrude from the membrane (on the cytoplasmic
side in bacteria, the matrix side in mitochondria). The dII
component spans the membrane. There are several high-reso-Abbreviations: AcPdAD+, acetyl pyridine adenine dinucleotides (oxi-
dised form); NAD(H), signiﬁes both the oxidised and reduced forms of
the nucleotide (etc.)
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doi:10.1016/j.febslet.2005.04.026lution structures, with diﬀerent bound ligands, of isolated dI
and dIII and of a dI2dIII1 complex (reviewed [2]). The hy-
dride-transfer site of transhydrogenase is at the interface be-
tween dI and dIII. This site is probably P 30 A˚ from the
proton translocation pathway in dII and coupling, therefore,
must be eﬀected by a long-distance conformational change.
Experiments suggest that an important consequence of the
conformational change is to alter the binding energy for
NADP(H) [1,3–5].
The Zn2+ ion can be coordinated by functional groups in
proteins, including thiolate, carboxylate and imidazol, and
by water molecules [6]. It can bind tightly to its ligands but ex-
change them rapidly. Of course, Zn2+ has an important cata-
lytic/structural role in many proteins but some enzymes are
inhibited by low concentrations of the ion and this can pro-
vide valuable insights into reaction mechanism. Of particular
interest in bioenergetics is the ﬁnding that Zn2+ inhibits pro-
ton-transfer steps in photosynthetic reaction centres [7,8], cyto-
chrome bc1 complexes [9,10], cytochrome c oxidase [11–13] and
voltage-gated proton channels [14].
In this report, we show that low concentrations of Zn2+ and
Cd2+ strongly inhibit ‘‘reverse’’ transhydrogenation in bacte-
rial membranes (cf. Eq. (1)) but, depending on the pH, they
either have no eﬀect on, or stimulate, ‘‘cyclic’’ transhydrogena-
tion (see [3]). Reverse and cyclic transhydrogenation share
some but not all of their reaction steps. We can, therefore,
identify the steps that are aﬀected by Zn2+ and Cd2+. They
are the steps – NADP(H) binding and release – that are
thought to be associated with proton translocation through
dII.2. Materials and methods
Cells of the S1 strain of Rhodospirillum rubrum were grown under
photoheterotrophic conditions at 30 C, and chromatophores (inverted
cytoplasmic membranes) were prepared from harvested cells by
French-Press treatment in 10% sucrose, 50 mM Tris–HCl, pH 8.0
[15]. The chromatophores were washed by centrifugation in 20 mM
HEPES–NaOH, pH 7.5, containing 4 lM NADP+ and were re-sus-
pended in 20 mM HEPES–NaOH, pH 7.5, supplemented with 50%
glycerol for storage at 20 C. The bacteriochlorophyll content of di-
luted membrane suspensions was determined from the absorbance at
880 nm using an extinction coeﬃcient of 140 mM1 cm1 [16].
Cells of Escherichia coli strain JM109 harbouring the plasmid pSA2
[17] – this system overexpresses transhydrogenase – were grown aero-
bically at 37 C in Luria–Bertani medium containing 0.1 mg ml1
ampicillin. Cytoplasmic membrane vesicles were prepared from har-
vested cells by French-Press treatment in 50 mM Tris–HCl, pH 8.0,
1 mM EDTA, 1 mM dithiothreitol [3]. The membrane vesicles were
washed in 50 mM HEPES–NaOH, pH 7.2, re-suspended in the sameblished by Elsevier B.V. All rights reserved.
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The protein concentration was determined using the bicinchoninic acid
assay [18].
The isolated dI and dIII components of R. rubrum transhydrogenase
were expressed from plasmids pCD1 and pNIC2 in E. coli strains C600
and BL21(DE3), respectively [19,20]. They were puriﬁed by column
chromatography and stored, as described [19,21]. Protein concentra-
tion was determined using the microtannin assay [22].
Transhydrogenase activities of membranes and of dI2dIII1 com-
plexes were measured at 25 C using buﬀers selected for their low bind-
ing aﬃnity for Zn2+ and Cd2+ [14]. The reduction of acetyl pyridine
adenine dinucleotides (oxidised form) (AcPdAD+) was measured by
following the absorbance change at 375 nm using an extinction coeﬃ-
cient of 6.1 mM1 cm1 [23]. Experiments in mutational inactivation
in E. coli [34], and resolution/reconstitution in R. rubrum [15], show
that transhydrogenase is the only enzyme that catalyses AcPdAD+
reduction by NAD(P)H at a signiﬁcant rate in the membranes used
in this report. Fits to the data were constructed in SigmaPlot (version
7.101) using non-linear regression as described in the ﬁgure legends.Ra
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Fig. 2. The eﬀects of Zn2+ and of Cd2+ on reverse and cyclic
transhydrogenase activities of R. rubrum membranes and of dI2dIII1
complexes. Top panels (A) and (B): R. rubrum membranes (10 nmol
bacteriochlorophyll) were suspended in 1.0 ml 50 mMHEPES–NaOH,
pH 7.2, containing 2 mM MgCl2 and 4.5 lM carbonylcyanide-p-
triﬂuoromethoxyphenylhydrazone. BChl, bacteriochlorophyll. Bottom
panels (C) and (D): R. rubrum dI (100 pmol) and dIII (30 pmol) were
suspended in 1.0 ml 50 mM HEPES–NaOH, pH 7.2, containing 2 mM
MgCl2 (dIII is almost saturated with dI in these conditions and rates
are expressed as a turnover number for dIII). Reverse transhydroge-
nation (open triangles) and cyclic transhydrogenation (closed circles)
were measured using the nucleotide concentrations described in Fig. 1.
Zn2+, panels (A) and (C), and Cd2+, panels (B) and (D), were added as
the chloride salts. The lines through the data points are binding
isotherms constructed as in Fig. 1.3. Results
Transhydrogenase activity is conveniently measured in the
‘‘reverse’’ direction (cf. Eq. (1)) by following the reduction of
AcPdAD+ (an analogue of NAD+) by NADPH
AcPdADþ þNADPH! AcPdADHþNADPþ ð2Þ
Zn2+ (Fig. 1, panels A–C) and Cd2+ (data not shown) at low
concentrations strongly inhibited the reverse transhydrogenase
activity of E. coli membranes. The concentration of metal ion
required to give 50% inhibition was greater at low pH. If other
chelation sites do not distort the system, this indicates that me-
tal-ion binding to the transhydrogenase is competitive with
proton binding. The observation compares with results on
other proteins whose function involves proton-transfer steps
[7–14]. Reverse transhydrogenase activity of R. rubrum chro-
matophores was also inhibited by either Zn2+ or Cd2+ (Fig.
2, panels A and B, respectively). Zn2+ lowered both the Vmax
and the apparent Km values for AcPdAD
+ and NADPH
(Fig. 3). We have been unable to ﬁnd data in the literature
for the stability constants of complexes of either Zn2+ or[Zn
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Fig. 1. The eﬀects of Zn2+ on reverse and cyclic transhydrogenase activities o
in 1.0 ml buﬀer containing 2 mM MgCl2 and the uncoupler, carbonylcyani
genation (top panels) was measured as the reduction of AcPdAD+ (200 lM)
measured as the reduction of AcPdAD+ (200 lM) by NADH (200 lM) in th
50 mMMes-NaOH, pH 6.3, in panels (B) and (E), it was 50 mM HEPES–Na
pH 8.0. Initial rates of reduction of AcPdAD+ are shown. Zn2+ (given as the
salt. The lines through the data points are binding isotherms constructed usin
is low compared with the concentration of free metal ion, and that inhibitioCd2+ and nicotinamide nucleotides but there may be some
binding. However, in our experiments, the nucleotides and
Mg2+ were present in an excess over the transition-metal ions.
Eﬀects of Zn2+/Cd2+ on nucleotide concentration would, there-
fore, have been insigniﬁcant. The excess nucleotide may have
lowered the concentration of free Zn2+/Cd2+: for this reason
(and because lipid and other proteins in the membranes may2+] (µM)
Cyclic
pH 8.0
everse
pH 7.2
Reverse
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Cyclic
H 7.2
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FE
f E. coli membranes. E. coli membranes (16 lg protein) were suspended
de-p-triﬂuoromethoxyphenylhydrazone (4.5 lM). Reverse transhydro-
by NADPH (200 lM). Cyclic transhydrogenation (lower panels) was
e presence of NADP+ (50 lM). In panels (A) and (D), the buﬀer was
OH, pH 7.2, and in panels (C) and (F), it was 50 mM HEPES–NaOH,
total concentration, uncorrected for binding) was added as the chloride
g SigmaPlot assuming that the concentration of metal-ion binding sites
n of the reverse reaction is complete at high concentrations of Zn2+.
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Fig. 3. The dependence on NADPH and AcPdAD+ concentrations of
reverse transhydrogenase activity of R. rubrum membranes in the
presence and absence of Zn2+. Measurements as in Fig. 2. Panel (A),
200 lM NADPH and varying AcPdAD+; panel (B) 200 lM AcP-
dAD+, varying NADPH. Closed circles, no added Zn2+; open
triangles, plus 15 lM ZnCl2. The lines through the data points were
constructed using SigmaPlot assuming Michaelis–Menten kinetics.
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Scheme 1.
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binding to the transhydrogenase from Figs. 1 and 2. The addi-
tion of 0.2 mM EDTA to membranes inhibited by 0.1 mM
Zn2+ promptly restored the transhydrogenation rate, indicat-
ing complete reversibility (data not shown).
Bacterial transhydrogenase also catalyses a so-called ‘‘cyclic
reaction’’ in which AcPdAD+ is reduced by NADH instead of
NADPH [3,24–26]. The reaction occurs because AcPdAD(H)
and NAD(H) bind to the same site on the enzyme. It does
not have physiological signiﬁcance but is useful in experimen-
tal studies. In the conditions normally employed for assay, cyc-
lic transhydrogenation proceeds by a set of reactions involving
bound NADP+ and NADPH (there are exceptions to this
which are not relevant here [26–28]). Thus, the cyclic reaction
can be summarised as shown in Scheme 1.
NADH from solution binds to the enzyme and reduces pre-
bound NADP+ (step 1). The resulting NAD+ dissociates and is
replaced by AcPdAD+, which then oxidises the bound
NADPH (step 2). Dissociation of AcPdADH completes the
process. Importantly, NADP+ and NADPH can either remain
bound to the enzyme for multiple turnovers of the cyclic reac-
tion or they can dissociate and be replaced by NADP(H) from
solution (dashed lines). The cyclic reaction catalysed by E. coli
transhydrogenase is rapid at pH 6.0 and declines at higher pH
[3]. Fig. 1D–F shows that the low concentrations of Zn2+,
either strongly stimulated (high pH), or had no eﬀect on
(low pH), the cyclic reaction.
The cyclic reaction catalysed by R. rubrum membranes was
also stimulated by Zn2+ and by Cd2+ (Fig. 2A and B). The
R. rubrum transhydrogenase is a particularly useful system
for study. Firstly, in this organism, the dI component of the
enzyme exists as a separate polypeptide, which can be removed
from chromatophore membranes simply by washing. This re-
sults in parallel loss of reverse and cyclic transhydrogenase
activities, which can then be restored by reconstitution with
puriﬁed, recombinant dI [26]. Secondly, mixtures of recombi-
nant dI and dIII from R. rubrum form stable dI2dIII1 com-
plexes. In the absence of the membrane-spanning dII,
NADP(H) binds very tightly to dIII. Thus, reverse transhydro-
genase activity in dI2dIII1 complexes, limited by the rate of
NADP+ release, is extremely slow: 103-fold less than in the in-
tact enzyme [21,29,30]. However, the cyclic reaction in dI2dIII1
complexes is rapid, with about the same turnover (30 s1) asthat in the intact enzyme. Zn2+ and Cd2+ had very little eﬀect
on the cyclic reaction catalysed by this dI2dIII1 complex (Fig.
2C and D).4. Discussion
There is only 49.6% identity between the amino acid se-
quences of R. rubrum and E. coli transhydrogenases. Neverthe-
less, there are striking similarities in the eﬀects of Zn2+ and
Cd2+ on the kinetic properties of the two enzymes that might
reﬂect an important underlying principle in the mechanism
of proton translocation. For both enzymes, the diﬀerential ef-
fects of Zn2+ and of Cd2+ on the reverse and cyclic reactions
help us identify the steps that are modiﬁed by the metal ions.
AcPdAD+ binding and AcPdADH release from dI, and the
on-enzyme hydride transfer between NADPH and AcPdAD+,
summarised by step (2) in Scheme 1, are common to both re-
verse and cyclic transhydrogenation. Since cyclic transhydro-
genation is not inhibited by Zn2+ and Cd2+ up to 100 lM,
these steps cannot be the site of metal-ion inhibition in the re-
verse reaction. On the other hand, NADPH binding and
NADP+ release (dashed lines in Scheme 1) are obligatory in re-
verse but not in cyclic transhydrogenation. One or both of
these steps must, therefore, be inhibited by Zn2+/Cd2+. The
apparent Km for NADPH during reverse transhydrogenation
is slightly decreased in the presence of Zn2+ (Fig. 3). However,
the NADPH-binding step is kinetically complex (see below)
and the Km is not a simple indicator of the enzyme-nucleotide
dissociation constant.
The stimulation of the cyclic reaction by Zn2+ and Cd2+ in
the membrane-bound transhydrogenases (Figs. 1 and 2) is also
readily explained by a speciﬁc inhibitory eﬀect on steps involv-
ing NADP(H) binding/release. Thus, in the absence of the me-
tal ions, net dissociation of either NADP+ or NADPH from
the enzyme would lead to a restricted rate of cyclic transhydro-
genation due to depleted populations of E.NADPH and
E.NADP+ in the steady-state (see Scheme 1). Inhibition by
Zn2+/Cd2+ of NADP(H) dissociation would elevate the popu-
lations of E.NADPH and E.NADP+ leading to stimulation
of the rate. The decline in the rate of cyclic transhydrogenation
by the E. coli enzyme at high pH was attributed to weaker
binding of NADP(H) [3]. The more extensive stimulation of
the rate by Zn2+ at high pH (Fig. 1) strongly supports this view.
As the concentration of the metal-ion approaches saturation,
when presumably the NADP(H) site on transhydrogenase
NADH
NADP+
dI
dIII
dII
H+
Zn2+
Fig. 4. Simpliﬁed model to indicate the probable site of Zn2+
inhibition in transhydrogenase. The enzyme is shown with NADH
bound to dI and NADP+ bound to an open state of dIII. The thick
horizontal lines indicate the probable position of the membrane.
Proton translocation through dII is coupled by a conformational
change (the zigzag line) to events at the NADP(H)-binding site that
lead to nucleotide occlusion and subsequent H transfer (see text).
Zn2+ is suggested to block a proton-transfer step in dII.
2866 S.J. Whitehead et al. / FEBS Letters 579 (2005) 2863–2867tends towards full occupation, the cyclic reaction is almost
independent of pH in the measured range.
The reduction of AcPdAD+ by NADPH in reverse transhy-
drogenation is unequivocally coupled to proton translocation
across the bacterial membrane [25,31]. In an earlier study,
we presented evidence that the cyclic reaction is not [25]. This,
and other data, indicates that proton translocation by transhy-
drogenase is linked speciﬁcally with NADP(H) binding/release
[1]. The model is represented diagrammatically in Fig. 4. It was
suggested that the protonation/deprotonation reactions associ-
ated with translocation through dII alter the binding energy
for NADP(H) by shifting the dIII conformation between an
‘‘open’’ and an ‘‘occluded’’ state. NADP(H) binding and re-
lease can occur only in the open state, and hydride transfer
(to or from NAD(H) on dI) takes place only in the occluded
state [1]. The dashed lines in Scheme 1 are, therefore, more
properly summarised as follows:
Eopen þNADPðHÞ $ Eopen.NADPðHÞ$ Eoccluded.NADPðHÞ
ð3Þ
where the starred reaction is linked with steps in proton trans-
location. We suggest that Zn2+ and Cd2+ interfere with proton
translocation in dII and hence inter-conversion of the open
and occluded states of dIII. These steps are obligatory in (pro-
ton-translocating) reverse transhydrogenation, and therefore,
we see inhibition of the reaction by the metal ions. However,
NAD(H) and AcPdAD(H) can bind to, and be released from,
the enzyme in either the open or occluded states [32]. The (non-
proton-translocating) cyclic reaction in membranes can there-
fore proceed entirely within the occluded state. It is not subject
to either Zn2+ or Cd2+ inhibition, though it can be stimulated
by these ions through a block in the inter-conversion of the
open and occluded states maintaining a larger population of
Eoccluded.NADP(H), as indicated above. Kinetics experiments
suggest that isolated dI2dIII1 complexes, in the absence of
the membrane-spanning dII, are locked in the occluded state
[21,29], and X-ray data provide a structural explanation for
this [33]. Hence, we can understand why the complexes can
catalyse a high rate of cyclic transhydrogenation, which is
unaﬀected by either Zn2+ or Cd2+ (Fig. 2C and D).
The conclusion that Zn2+ and Cd2+ may aﬀect the proton-
translocation steps in transhydrogenase has a parallel with re-cent experiments on other proteins. There is an indication that
proton-transfer steps in photosynthetic reaction centres [7,8],
cytochrome bc1 complexes [9,10], cytochrome c oxidase [11–
13] and voltage-gated proton channels [14] are inhibited by
Zn2+ and Cd2+. In the case of reaction centres, there are crystal
structures of the protein showing the metal ions bound to an
Asp and two His residues in, or close to, the proton pathway
to ubiquinone in the QB site [7]. There is no crystal structure
of the intact transhydrogenase but mutagenesis studies have
suggested that bHis91 and bAsp213 in dII of the E. coli en-
zyme are important in turnover, and the possibility that they
may participate in proton translocation has been discussed
[34–39]. bHis91 is thought to be located in putative transmem-
brane helix 9 of dII, and bAsp213 in the short cytoplasmic-side
loop between TM helices 12 and 13. We might speculate that
inhibition by Zn2+ and Cd2+ could result from the binding
of these metal ions to bHis91 or bAsp213 or both, and exper-
iments are in progress to investigate this possibility.
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